4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-23-010637
Chief Commercial Officer acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Francomano Robert Chief Commercial Officer | 2023-02-02 | Grant or award | +12,000 | 12,000 | D | ||
| Derivatives | |||||||
| Francomano Robert Chief Commercial Officer | 2023-02-02 | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | D | ||
Loading xslF345X03/tm235353d6_4seq1.xml…